| 股號 / 名稱 | 營業現金流 | 自由現金流 | 淨現金流 |
| NVO 諾和諾德 | 7,253,553,240.0 | 4,828,465,440.0 | 2,147,260,680.0 |
| SYK 史賽克 | 1,540,000,000.0 | 1,353,000,000.0 | 881,000,000.0 |
| ZBH Zimmer Biomet Holdings Inc | 418,700,000.0 | 267,700,000.0 | 735,800,000.0 |
| BSX Boston Scientific Corp | 1,343,000,000.0 | 1,162,000,000.0 | 735,000,000.0 |
| ABT 美國雅培 | 2,787,000,000.0 | 2,291,000,000.0 | 560,000,000.0 |
| RMD 瑞思邁 | 457,321,000.0 | 411,542,000.0 | 174,398,000.0 |
| PHG Koninklijke Philips NV | 395,496,460.0 | 211,244,400.0 | 116,184,420.0 |
| HCM HUTCHMED (China) Ltd | -73,391,000.0 | -74,725,000.0 | 86,392,000.0 |
| ORMP Oramed Pharmaceuticals Inc | -1,625,000.0 | -1,625,000.0 | 36,382,000.0 |
| INMD Inmode Ltd | 24,467,000.0 | 24,333,000.0 | 36,200,000.0 |
| BRBR Bellring Brands Inc | 169,100,000.0 | 168,100,000.0 | 34,200,000.0 |
| ATRC AtriCure Inc | 26,716,000.0 | 24,111,000.0 | 30,069,000.0 |
| BIO Bio Rad Laboratories Inc | 120,900,000.0 | 89,200,000.0 | 26,500,000.0 |
| NVST Envista Holdings Corp | 78,700,000.0 | 67,900,000.0 | 23,300,000.0 |
| FLGC Flora Growth Corp | 100,000.0 | 91,000.0 | 12,423,000.0 |
| NEOG Neogen Corp | 10,853,000.0 | -13,149,000.0 | 9,879,000.0 |
| MDT 美敦力 | 925,000,000.0 | 457,000,000.0 | 9,000,000.0 |
| EYE National Vision Holdings Inc | 46,634,000.0 | 30,268,000.0 | 7,585,000.0 |
| XGN Exagen Inc | 2,944,000.0 | 2,669,000.0 | 5,619,000.0 |
| PAHC Phibro Animal Health Corp | 9,302,000.0 | -4,504,000.0 | 4,730,000.0 |
| UTMD Utah Medical Products Inc | 3,878,000.0 | 3,851,000.0 | 2,088,000.0 |
| CLRB Cellectar Biosciences Inc | -4,275,120.0 | 1,513,260.0 | |
| SNES Senestech Inc | -1,379,000.0 | -1,421,000.0 | 1,223,000.0 |
| RMTI Rockwell Medical Inc | -1,307,000.0 | -1,536,000.0 | 1,128,000.0 |
| OMER Omeros Corp | -18,473,000.0 | -18,484,000.0 | 491,000.0 |
| IMCC IM Cannabis Corp | -2,513,837.7 | -2,516,712.3 | 278,836.2 |
| INFU InfuSystem Holdings Inc | 8,493,000.0 | 7,387,000.0 | 235,000.0 |
| NEPH Nephros Inc | 99,000.0 | 97,000.0 | |
| ZVIA Zevia PBC | 116,000.0 | -65,000.0 | -272,000.0 |
| ICUI ICU Medical Inc | 56,710,000.0 | 24,961,000.0 | -293,000.0 |
| CERS Cerus Corp | 1,927,000.0 | 94,000.0 | -322,000.0 |
| UG United-Guardian Inc | 1,011,000.0 | 995,760.0 | -907,650.0 |
| GCTK GlucoTrack Inc | -4,621,000.0 | -4,688,000.0 | -1,686,000.0 |
| MYO Myomo Inc | -1,828,780.0 | -2,881,630.0 | -1,686,880.0 |
| ICCC ImmuCell Corp | -1,182,580.0 | -1,776,500.0 | -2,112,290.0 |
| BLFS BioLife Solutions Inc | 6,104,000.0 | 2,429,000.0 | -2,421,000.0 |
| CTSO Cytosorbents Corp | -2,577,000.0 | -2,522,000.0 | -2,668,000.0 |
| CAPR Capricor Therapeutics Inc | -19,688,790.0 | -23,698,210.0 | -3,730,810.0 |
| APYX Apyx Medical Corp | -3,536,000.0 | -4,055,000.0 | -4,166,000.0 |
| ZYXI Zynex Inc | -6,308,000.0 | -6,326,000.0 | -4,284,000.0 |
| VERU Veru Inc | -5,482,300.0 | -5,482,300.0 | -5,008,240.0 |
| WRBY Warby Parker Inc | 17,974,000.0 | -1,516,000.0 | -6,024,000.0 |
| PHGE Biomx Inc | -7,183,000.0 | -7,117,000.0 | |
| VMD Viemed Healthcare Inc | 18,367,000.0 | 10,731,000.0 | -8,893,000.0 |
| EOLS Evolus Inc | -14,669,000.0 | -16,827,000.0 | -18,215,000.0 |
| VALN Valneva SE | -20,473,103.1 | -21,257,054.54 | -20,943,708.68 |
| MRVI Maravai LifeSciences Holdings Inc | -15,150,000.0 | -18,076,000.0 | -26,333,000.0 |
| OMI Owens & Minor Inc | -172,520,000.0 | -230,349,000.0 | -30,921,000.0 |
| MGNX MacroGenics Inc | -30,186,000.0 | -30,612,000.0 | -50,557,000.0 |
| QDEL QuidelOrtho Corp | -45,500,000.0 | -94,700,000.0 | -53,600,000.0 |
| TGTX TG Therapeutics Inc | -23,153,000.0 | -23,233,000.0 | -55,032,000.0 |
| QTRX Quanterix Corp | -41,249,000.0 | -41,926,000.0 | -93,903,000.0 |
載入數據中...
最新要聞
和醫療產品相關的產業概念股
醫療產品概念股相關指標排名
醫療產品每月營收
醫療產品每股盈餘
醫療產品每股淨值
醫療產品損益表
醫療產品總資產
醫療產品負債和股東權益
醫療產品現金流量表
醫療產品利潤比率
醫療產品營業費用率拆解
醫療產品杜邦分析
醫療產品ROE / ROA
醫療產品經營週轉能力
醫療產品營運週轉天數
醫療產品現金股利發放率
醫療產品財務結構比率
醫療產品流速動比率
醫療產品利息保障倍數
醫療產品現金流量分析
醫療產品營業現金流對淨利比
醫療產品盈餘再投資比率
醫療產品月營收成長率
醫療產品營收成長率
醫療產品毛利成長率
醫療產品營業利益成長率
醫療產品稅後淨利成長率
醫療產品每股盈餘成長率
醫療產品本益比評價
醫療產品股價淨值比評價
醫療產品現金股利殖利率
醫療產品平均現金股息殖利率
醫療產品董監持股比例
醫療產品董監持股質押比例